Macrophages and Autoantibodies in Demyelinating Diseases

Myelin phagocytosis by macrophages has been an essential feature of demyelinating diseases in the central and peripheral nervous systems, including Guillain–Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and multiple sclerosis (MS). The discovery of autoantibodies, i...

Full description

Bibliographic Details
Main Authors: Haruki Koike, Masahisa Katsuno
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/4/844
_version_ 1797538427790426112
author Haruki Koike
Masahisa Katsuno
author_facet Haruki Koike
Masahisa Katsuno
author_sort Haruki Koike
collection DOAJ
description Myelin phagocytosis by macrophages has been an essential feature of demyelinating diseases in the central and peripheral nervous systems, including Guillain–Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and multiple sclerosis (MS). The discovery of autoantibodies, including anti-ganglioside GM1 antibodies in the axonal form of GBS, anti-neurofascin 155 and anti-contactin 1 antibodies in typical and distal forms of CIDP, and anti-aquaporin 4 antibodies in neuromyelitis optica, contributed to the understanding of the disease process in a subpopulation of patients conventionally diagnosed with demyelinating diseases. However, patients with these antibodies are now considered to have independent disease entities, including acute motor axonal neuropathy, nodopathy or paranodopathy, and neuromyelitis optica spectrum disorder, because primary lesions in these diseases are distinct from those in conventional demyelinating diseases. Therefore, the mechanisms underlying demyelination caused by macrophages remain unclear. Electron microscopy studies revealed that macrophages destroy myelin as if they are the principal players in the demyelination process. Recent studies suggest that macrophages seem to select specific sites of myelinated fibers, including the nodes of Ranvier, paranodes, and internodes, for the initiation of demyelination in individual cases, indicating that specific components localized to these sites play an important role in the behavior of macrophages that initiate myelin phagocytosis. Along with the search for autoantibodies, the ultrastructural characterization of myelin phagocytosis by macrophages is a crucial step in understanding the pathophysiology of demyelinating diseases and for the future development of targeted therapies.
first_indexed 2024-03-10T12:30:19Z
format Article
id doaj.art-d6075ad52cff4d5496e98ab6e5f67ff6
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T12:30:19Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-d6075ad52cff4d5496e98ab6e5f67ff62023-11-21T14:42:59ZengMDPI AGCells2073-44092021-04-0110484410.3390/cells10040844Macrophages and Autoantibodies in Demyelinating DiseasesHaruki Koike0Masahisa Katsuno1Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, JapanDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, JapanMyelin phagocytosis by macrophages has been an essential feature of demyelinating diseases in the central and peripheral nervous systems, including Guillain–Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and multiple sclerosis (MS). The discovery of autoantibodies, including anti-ganglioside GM1 antibodies in the axonal form of GBS, anti-neurofascin 155 and anti-contactin 1 antibodies in typical and distal forms of CIDP, and anti-aquaporin 4 antibodies in neuromyelitis optica, contributed to the understanding of the disease process in a subpopulation of patients conventionally diagnosed with demyelinating diseases. However, patients with these antibodies are now considered to have independent disease entities, including acute motor axonal neuropathy, nodopathy or paranodopathy, and neuromyelitis optica spectrum disorder, because primary lesions in these diseases are distinct from those in conventional demyelinating diseases. Therefore, the mechanisms underlying demyelination caused by macrophages remain unclear. Electron microscopy studies revealed that macrophages destroy myelin as if they are the principal players in the demyelination process. Recent studies suggest that macrophages seem to select specific sites of myelinated fibers, including the nodes of Ranvier, paranodes, and internodes, for the initiation of demyelination in individual cases, indicating that specific components localized to these sites play an important role in the behavior of macrophages that initiate myelin phagocytosis. Along with the search for autoantibodies, the ultrastructural characterization of myelin phagocytosis by macrophages is a crucial step in understanding the pathophysiology of demyelinating diseases and for the future development of targeted therapies.https://www.mdpi.com/2073-4409/10/4/844demyelinationelectron microscopymacrophageparanodepathogenesispathology
spellingShingle Haruki Koike
Masahisa Katsuno
Macrophages and Autoantibodies in Demyelinating Diseases
Cells
demyelination
electron microscopy
macrophage
paranode
pathogenesis
pathology
title Macrophages and Autoantibodies in Demyelinating Diseases
title_full Macrophages and Autoantibodies in Demyelinating Diseases
title_fullStr Macrophages and Autoantibodies in Demyelinating Diseases
title_full_unstemmed Macrophages and Autoantibodies in Demyelinating Diseases
title_short Macrophages and Autoantibodies in Demyelinating Diseases
title_sort macrophages and autoantibodies in demyelinating diseases
topic demyelination
electron microscopy
macrophage
paranode
pathogenesis
pathology
url https://www.mdpi.com/2073-4409/10/4/844
work_keys_str_mv AT harukikoike macrophagesandautoantibodiesindemyelinatingdiseases
AT masahisakatsuno macrophagesandautoantibodiesindemyelinatingdiseases